Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α

Chinese Medical Journal

Volumn 125, Issue 6, 2012, Pages 1095-1103

  Zhu, Hong ^a   Luo, Shun Feng ^b   Wang, Ji ^a   Li, Xin ^a   Wang, Hui ^a   Pu, Wang Yang ^a   Zhang, Hong ^a   Zhuang, Zhi Xiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; HepG2 cells; Hypoxia inducible factor 1

Indexed keywords

1, 4 DIAMINO 1, 4 BIS (2 AMINOPHENYLTHIO) 2, 3 DICYANOBUTADIENE; GLUCOSE; GLYCOPROTEIN P; HEPATITIS B VIRUS X PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

DRUG RESISTANCE, NEOPLASM; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; TUMOR MICROENVIRONMENT;

EID: 84862266744     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.06.024     Document Type: Article

References (41)

1. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radiographic, and cytogenetic studies. Cancer Res 1970; 30: 1174-1184.
2. Shukla S, Wu CP, Ambudkar SV. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin Drug Metab Toxicol 2008; 4: 205-223.
3. Fojo AT, Menefee M. Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR). Semin Oncol 2005; 32: S3-S8.
4. Yuan H, Li X, Wu J, Li J, Qu X, Xu W, et al. Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance. Curr Med Chem 2008; 15: 470-476.
5. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin - one single nature. Biochim Biophys Acta 2005; 1756: 1-24.
6. Shicang Y, Guijun H, Guisheng Q, Yuying L, Guoming W, Ruiling G Efficacy of chemotherapeutic agents under hypoxic conditions in pulmonary adenocarcinoma multidrug resistant cell line. J Chemother 2007; 19: 203-211.
7. Elliott T, Sethi T. Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev Anticancer Ther 2002; 2: 449-459.
8. Kim KR, Moon HE, Kim KW. Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med 2002; 80: 703-714.
9. Zhu H, Luo SF, Guan J, Zhang WG, Zhang BX, Chen XP Multidrug resistance induced by hypoxia in hepatocellular carcinoma. J Hepatol 2004; 40 Suppl 1: 105-106.
10. Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX. Formation of multidrug resistance of hepatocellular carcinoma induced by microenvironment and its mechanism. China J Exp Surg (Chin) 2005; 22: 1315-1318.
11. Guan J, Chen XP, Zhu H, Luo SF, Cao B, Ding L. Involvement of extracellular signal-regulated kinase/ mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. World J Gastroenterol 2004; 10: 3522-3527.
12. Luo SF, Chen XP, Zhu H, Zhang BX, Guan J. Role of hypoxia-inducible factor-1-a in formation of multidrug resistance induced by microenvironment in hepatocellular carcinoma. Chin-Ge J Clin Oncol 2006; 5: 178-183.
13. Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX. Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res 2005; 24: 565-574.
14. Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX, et al. Hypoxia-inducible factor-1a-dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell. Chin J Surg (Chin) 2005; 43: 277-281.
15. Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX, et al. The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma. Chin J Surg (Chin) 2007; 45: 917-920.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. NewYork: Cold Sping Harbor Laboratory Press; 1989: 870-877.
17. Wang JS, Liu X, Xue ZY, Alderman L, Tilan JU, Adenika R, et al. Effects of aging on time course of neovascularization-related gene expression following acute hindlimb ischemia in mice. Chin Med J 2011; 124: 1075-1081.
18. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
19. Kim HJ, Chung H, Yoo YG, Kim H, Lee JY, Lee MO, et al. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 2007; 5: 321-329.
20. Zhu DM, Li DC, Zhang ZX, Zhang XY Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma. Chin Med J 2008; 121: 2258-2264.
21. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002; 62: 3387-3394.
22. Wartenberg M, Ling FC, Muschen M, Klein F, Acker H, Gassmann M, et al. Regulation of the multidrug resistance transporter p-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 2003; 17: 503-505.
23. Minet E, Arnould T, Michel G, Roland I, Mottet D, Raes M, et al. Erk activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett 2000; 468: 53-58.
24. Minet E, Mchel G, Mottet D, Raes M, Mchiels C. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 2001; 31: 847-855.
25. Yoo YG, Cho S, Park S, Lee MO. The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha. FEBS Lett 2004; 577: 121-126.
26. Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci 2007; 64: 2170-2180.
27. Bilton RL, Booker GW The subtle side to hypoxia inducible factor (hifalpha) regulation. Eur J Biochem 2003; 270: 791-798.
28. Lu Y, Liang K, Li X, Fan Z. Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1alpha. Mol Cancer 2007; 6: 63.
29. Shi YH, Bingle L, Gong LH, Wang YX, Corke KP, Fang WG. Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in t47d breast cancer cells. Pathology 2007; 39: 396-400.
30. Mchiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of map kinases. IUBMB Life 2001; 52: 49-53.
31. Mottet D, Mchel G, Renard P, Ninane N, Raes M, Mchiels C. Role of erk and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 2003; 194: 30-44.
32. Salceda S, Beck I, Srinivas V, Caro J. Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int 1997; 51: 556-559.
33. Andresen BT, Rizzo MA, Shome K, Romero G The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett 2002; 531: 65-68.
34. Boulton TG, Yancopoulos GD, Gregory JS, Slauqhter C, Moomaw C, Hsu J, et al. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 1990; 249: 64-67.
35. Katayama K, Yoshioka S, Tsukahara S, Mtsuhashi J, Sugimoto Y Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of p-glycoprotein. Mol Cancer Ther 2007; 6: 2092-2102.
36. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Strinqaro A, Gentile M, et al. The multidrug transporter p-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 2008; 128: 957-971.
37. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 1998; 17: 6573-6586.
38. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, et al. Identification of mapk phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 2006; 281: 33095-33106.
39. Triantafyllou A, Mylonis I, Simos G, Bonanou S, Tsakalof A. Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radic Biol Med 2008; 44: 657-670.
40. Depping R, Steinhoff A, Schindler SG, Friedrich B, Faqerlund R Metzen E, et al. Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway. Biochim Biophys Acta 2008; 1783: 394-404.
41. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. P42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274: 32631-32637.